Clinical Trials Directory

Trials / Suspended

SuspendedNCT06127550

taVNS for Letter Learning in Dyslexia

Effect of Non-invasive Vagus Nerve Stimulation on Letter Learning in Dyslexia

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
10 Years – 12 Years
Healthy volunteers
Accepted

Summary

This is a pilot study to establish feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) for improving letter-learning in adolescents with dyslexia. The main goals of the study are to 1) evaluate whether children in this age range will tolerate low level stimulation over the course of multiple sessions, 2) determine whether low level taVNS improves novel letter learning in dyslexia, and 3) evaluate the effect of low level taVNS on the brain's response to letters. Participants will complete fMRI before training, immediately after training, and a few weeks after training ends. Training will consist of six 30-minute lessons during which participants will learn novel letter-sound relationships while receiving either active or sham taVNS. Researchers will compare stimulation conditions to determine effect of this device on learning and neural plasticity.

Conditions

Interventions

TypeNameDescription
DEVICEactive taVNSlow level stimulation to the auricular branch of the vagus nerve
DEVICEsham taVNSdevice placed with no current administered

Timeline

Start date
2026-08-01
Primary completion
2028-08-01
Completion
2029-09-01
First posted
2023-11-13
Last updated
2025-12-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06127550. Inclusion in this directory is not an endorsement.